Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopram
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Epidemiological and clinical observations suggest the involvement of nicotinic acetylcholine receptors (nAChRs) in depressive illness. Nonetheless, there is no clearcut evidence that nicotine and/or nAChR antagonists produce an antidepressant effect. In the tail‐suspension test (C57/Bl male mice), nicotine (0.8–1.2 mg kg−1 s.c. or i.p.) given 15–60 min before the measurement exerted no effect on immobility. Given 30 min before the measurement, citalopram (2 mg kg−1) produced a slight decrease in immobility; coadministration of nicotine (0.8 mg kg−1, 15 but not 40 min before the test) to citalopram‐treated mice resulted in a robust decrease in immobility. Imipramine (4 mg kg−1) did not affect immobility, but given in combination with 0.8 mg kg−1 of nicotine (15 but not 40 min before the test), a decrease in immobility was observed. Nicotine (0.8 and 1.2 mg kg−1) also produced an enhancement in the anti‐immobility effect of imipramine (20 mg kg−1). We further investigated if nAChR antagonists would influence the antidepressant‐like effects of imipramine and citalopram. Unexpectedly, mecamylamine (1–2.5 mg kg−1) and dihydro‐β‐erythroidine (2 mg kg−1) potentiated the antidepressant‐like effect of imipramine (4–20 mg kg−1). Mecamylamine (2.5 mg kg−1) but not dihydro‐β‐erythroidine also increased the antidepressant‐like effect produced by 2 mg kg−1 of citalopram. The interaction between nAChR antagonists and antidepressants appeared synergistic. Neither nAChR ligands, antidepressants nor combinations of the two, affected locomotor activity. The present results demonstrate an unexpected interaction between nAChR ligands and imipramine and citalopram in the tail‐suspension test. British Journal of Pharmacology (2003) 139, 1196–1202. doi:10.1038/sj.bjp.0705359
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 2×
“The immobility was induced according to the procedure of Steru et al. (1985).”
BackgroundMethodSmoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
Effect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483 · cited 1×
“Finally, there is a hypothesis that emphasizes genetic factors predisposing to vulnerability to both major depression and smoking (Picciotto et al., 2002).”
BackgroundThe paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357
Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332 · cited 1×
“Other lines of evidence suggest that apart from its agonistic activity, nicotine might act as a functional antagonist at nAChRs due to its ability to produce a desensitization of nAChRs that follows activation phase (Fenster et al., 1997).”
BackgroundCigarette smoking and major depression
Covey, L. S., Glassman, A. H., & Stetner, F. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_04 · Cited by 302 · cited 1×
“In addition, depressed smokers are being more dependent on cigarettes, and the cessation of smoking is often followed by a depressive episode (Glassman et al., 1990; Lerman et al., 1996; Covey et al., 1998).”
BackgroundNicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Antidepressant effects of nicotine in an animal model of depression
Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark Jr, E., Janowsky, D. S., & Kling, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050879 · Cited by 209 · cited 1×
“In these rats, which in drug-free state demonstrate an exaggerated immobility in the forced swimming test, acute or chronic administration of nicotine (0.4mgkg 1 s.c.) significantly improved the performance in the forced swimming test (Tizabi et al., 1999).”
BackgroundInvestigation of mechanisms linking depressed mood to nicotine dependence
Lerman, C., Audrain, J., Orleans, C. T., Boyd, R., Gold, K., Main, D., & Caporaso, N. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00032-1 · Cited by 209 · cited 1×
“In addition, depressed smokers are being more dependent on cigarettes, and the cessation of smoking is often followed by a depressive episode (Glassman et al., 1990; Lerman et al., 1996; Covey et al., 1998).”
BackgroundAntidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00477-0 · Cited by 140
Effects of nicotine and mecamylamine on rat dorsal raphe neurons
Mihailescu, S., Palomero-Rivero, M., Meade-Huerta, P., Maza-Flores, A., & Drucker-Colı́n, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00658-x · Cited by 117
Kenny, P. J., File, S. E., & Neal, M. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752409.x · Cited by 100 · cited 2×
“For example, MEC at the low (0.5 mm) concentration antagonized nicotine-induced 5-HT release in rat hippocampal slices, but it itself stimulated 5-HT release at concentrations of 1–50 mm (Kenny et al., 2000).”
BackgroundInfluentialFerguson, S. M., Brodkin, J. D., Kenneth Lloyd, G., & Menzaghi, F. (2000) · Psychopharmacology · doi:10.1007/s002130000531 · Cited by 85
Depressive Characteristics of FSL Rats
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70 · cited 1×
“This effect was prevented by pretreatment with nAChR antagonist, mecamylamine (MEC), which by itself did not affect forced swimming response (Tizabi et al., 2000).”
Background
Cited by
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 703
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Shirayama, Y., & Chaki, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520773 · Cited by 225
“Indeed, it has also been reported that antidepressants inhibit nicotine receptors [51,60] and that nicotine receptor antagonist enhances the antidepressant effect of imipramine and citalopram [132].”
Background
Metadata
- Authors
- Popik, P., Kozela, E., & Krawczyk, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-07
- Volume
- 139
- Issue
- 6
- Pages
- 1196-1202
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2149749125
- Cited by
- 74
- References
- 16
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.